Pub Med Link to Aceves Publications

Selected Publications

  1. Aceves SS, Dohil R, Newbury RO, Bastian JF.  Topical viscous budesonide suspension for treatment of eosinophilic esophagitis. Journal of Allergy, Clin Immunology. 116:705-6. 2005
  2. Konikoff MR, Noel RJ, Blanchard C, Kirby C, Jameson SC, Buckmeier BK, Akers R, Cohen MB, Collins MH, Assa’ad AH, Aceves SS, Putnam PE, Rothenberg ME.  A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis.  Gastroenterology.  131:1381-91. 2006
  3. Aceves SS, Newbury RO, Dohil RD, Schwimmer J, Bastian JF.  Distinguishing eosinophilic esophagitis in children: clinical, endoscopic, and histologic features of an emerging disorder.  J Clin Gastroenterol.  41:252-6. 2007
  4. Aceves SS, Newbury RO, Dohil R, Bastian JF, Broide DH.  Esophageal remodeling in pediatric eosinophilic esophagitis.  J Allergy Clin Immunol.  119:206-12. 2007
  5. Aceves SS, Bastian JF, Newbury RO, Dohil RD.  Oral viscous budesonide: A potential new therapy for eosinophilic esophagitis.  Am J Gastroenterol.  102:1-9. 2007
  6. Aceves SS and Ackerman SJ.  Relationships between eosinophilic inflammation, tissue remodeling, and fibrosis in eosinophilic esophagitis.  Immunology Clin North America 29:197-211 2009 PMC2665721
  7. Aceves SS, Newbury RO, Dohil M, Bastian JF, Dohil R.  A symptom scoring tool identifies pediatric eosinophilic esophagitis patients and correlates with tissue inflammation.  Ann Allergy Asthma Immunol. 103(5):401-6.  2009
  8. Caldwell JM, Blanchard C, Collins MH, Putnam PE, Kaul A, Aceves SS, Bouska CA, Rothenberg ME. Glucocorticoid-regulated genes in eosinophilic esophagitis: a role for FKBP51.J Allergy Clin Immunol. 125(4):879-888. 2010
  9. Rothenberg ME, Spergel JM, Sherrill JD, Annaiah K, Martin LJ, Cianferoni A, Gober L, Kim C, Glessner J, Frackelton E, Thomas K, Blanchard C, Liacouras C, Verma R, Aceves S, Collins MH, Brown-Whitehorn T, Putnam PE, Franciosi JP, Chiavacci RM, Grant SF, Abonia JP, Sleiman PM, Hakonarson H. Common variants at 5q22 associate with pediatric eosinophilic esophagitis. Nat Genet. 42:289-91. 2010
  10. Aceves SS, Newbury RO, Chen D, Mueller J, Dohil R, Hoffman H, Bastian JF, Broide DH. Resolution of remodeling in eosinophilic esophagitis correlates with epithelial response to topical cortictosteroids. Allergy. 65:109-16. 2010. PMC2807896
  11. Dohil R, Newbury R, Fox L, Bastian J, Aceves S. Oral viscous budesonide is effective in children with eosinophilic esophagitis in a randomized placebo controlled trial. Gastroenterology. Gastroenterology. 139:418-29. 2010
  12. Aceves SS, Chen D, Newbury RO, Dohil R, Bastian J, Broide DH. Mast cells infiltrate the esophageal smooth muscle in eosinophilic esophagitis, express TGFβ1, and increase esophageal smooth muscle contraction. J Allergy Clinical Immunol. 126:1198-204. 2010
  13. Assa’ad AH, Gupta SK, Collin MH, Thomson M, Heath AT, Smith DA, Perschy TL, Jurgensen CH, Ortega HG, Aceves SS. An antibody against IL-5 reduces numbers of esophageal intraepithelial eosinophils in children with eosinophilic esophagitis. Gastroenterology, 141:1593-604. 2011
  14. Liacouras CA, Furuta GT, Hirano I, Atkins D, Attwood SE, Bonis PA, Burks AW, Chehade M, Collins MH, Dellon ES, Dohil R, Falk GW, Gonsalves N, Gupta SK, Katzka DA, Lucendo AJ, Markowitz JE, Noel RJ, Odze RD, Putnam PE, Richter JE, Romero Y, Ruchelli E, Sampson HA, Schoepfer A, Shaheen NJ, Sicherer SH, Spechler S, Spergel JM, Straumann A, Wershil BK, Rothenberg ME, Aceves SS. Eosinophilic esophagitis: Updated consensus recommendations for children and adults. J Allergy Clin Immunol. 128:3-20. 2011
  15. Rubinstein E, Cho JY, Rosenthal P, Chao J, Miller M, Pham A, Aceves SS, Varki A, Broide DH. Siglec-F inhibition reduces esophageal eosinophilia and angiogenesis in a mouse model of eosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 53:409-16. 2011
  16. Dohil R, Newbury RO, Aceves S. Transient PPI responsive esophageal eosinophilia may be a clinical sub-phenotype of pediatric eosinophilic esophagitis. Dig Dis Sci, 57:1413-9. 2012
  17. Aceves S, Hirano I, Furuta GT, Collins MH. Eosinophilic gastrointestinal disease—clinically diverse and histopathologically confounding. Semin Immunopathol. 34:715-31. 2012
  18. Straumann A, Aceves SS, Blanchard C, Collins MH, Furuta GT, Hirano I, Schoepfer AM, Simon D, Simon HU. Pediatric and adult eosinophilic esopahgitis: similarities and differences. Allergy. 67:477-90. 2012
  19. Otani IM, Anilkumar AA, Newbury RO, Bhagat M, Beppu LY, Dohil R, Broide DH, Aceves SS. Anti-IL-5 therapy reduces mast cells and IL-9 cells in pediatric eosinophilic esophagitis. J Allergy Clin Immunol. In press. 2013